Mylan CEO Bent Truth About Epipen Profit; Sadly Follows Path of Valeant, Turing Pharma
Controversial Mylan NV (Amsterdam) CEO Heather Bresch was grilled in a marathon committee hearing about the EpiPen’s pricing before Congress last week. But it turns out that several of her… Read more »